New oral Covid-19 drug in India: 'Faster recovery, less oxygen dependency'
BS Web Team Last Updated at May 9, 2021 18:26 IST
New oral Covid-19 drug in India: 'Faster recovery, less oxygen dependency'
An anti-COVID oral drug developed by the DRDO has been approved by the Drugs Controller General of India (DCGI) for emergency use as an adjunct therapy in moderate to severe coronavirus patients. Clinical trials of the drug 2-deoxy-D-glucose (2-DG) showed that it helps in faster recovery of hospitalised patients and reduces supplemental oxygen dependence.
Watch the video to know more.
POPULAR VIDEOS
MORE VIDEOS
-
OCTOBER 03, 2022, MONDAY
Samsung Galaxy Buds2 Pro: Unboxing feature-rich premium wireless ...
Launched alongside the Galaxy Z Fold4 and Flip4, the Galaxy Buds2 Pro ...
-
SEPTEMBER 30, 2022, FRIDAY
Explained: How inflation, repo rate and demand are linked
Inflation can be demand-driven price gain, or driven by supply-side ...
-
SEPTEMBER 29, 2022, THURSDAY
What are web intelligence tools that Sebi wants to use for ...
India's market regulator, Sebi, has reportedly decided to deploy a ...
-
SEPTEMBER 29, 2022, THURSDAY
Population & Climate change: Why countries are moving their capitals
Capital cities are important in a country’s political, cultural, and ...
-
SEPTEMBER 29, 2022, THURSDAY
International Safe Abortion Day: Abortion guidelines in India
Abortion is a simple health care intervention. However, lack of ...
-
ADVERTISEMENT
